Bronopol

Bronopol

SCHEMBL2680265

CC(Br)(C(O)O)[N+](=O)[O-].O=[N+]([O-])C(Br)(CO)CO

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.65
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL376975 0.85
Bronopol SCHEMBL23260 0.81
Bronopol SCHEMBL7069554 0.81 LMNA (1.00) LMNAALDH1A1
Bronopol SCHEMBL1702852 0.79 LMNA (0.85) LMNAALDH1A1
Bronopol SCHEMBL31490721 0.79 LMNA (0.94) LMNAALDH1A1
Bronopol SCHEMBL5076392 0.73 LMNA (0.81) LMNA
Bronopol SCHEMBL28857973 0.73 LMNA (0.81) LMNA
SCHEMBL1703576 0.73
Bronopol SCHEMBL31672719 0.71
Bronopol SCHEMBL7865473 0.71 LMNA (0.77) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120114728-A1 BIODELIVERY SYSTEMS GENERAL ELECTRIC COMPANY 2012-05-10 US disclosed
US-20100239626-A1 PROPANEDIOL DELIVERY SYSTEMS GENERAL ELECTRIC COMPANY 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120114728-A1 BIODELIVERY SYSTEMS LIPA, MGLL, LIPG LMNA 1648/4885ALDH1A1 4359/4885KDM4E 3444/4885
US-20100239626-A1 PROPANEDIOL DELIVERY SYSTEMS PLD2, PLD3, MGLL LMNA 1272/4885ALDH1A1 1948/4885KDM4E 3816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.